Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jun;64(6):2062–2069. doi: 10.1128/iai.64.6.2062-2069.1996

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.

L G Wayne 1, L G Hayes 1
PMCID: PMC174037  PMID: 8675308

Abstract

It was demonstrated previously that abrupt transfer of vigorously aerated cultures of Mycobacterium tuberculosis to anaerobic conditions resulted in their rapid death, but gradual depletion of available O2 permitted expression of increased tolerance to anaerobiosis. Those studies used a model based on adaptation of unagitated bacilli as they settled through a self-generated O2 gradient, but the model did not permit examination of homogeneous populations of bacilli during discrete stages in that adaptation. The present report describes a model based on culture of tubercle bacilli in deep liquid medium with very gentle stirring that keeps them in uniform dispersion while controlling the rate at which O2 is depleted. In this model, at least two stages of nonreplicating persistence were seen. The shift into first stage, designated NRP stage 1, occurred abruptly at a point when the declining dissolved O2 level approached 1% saturation. This microaerophilic stage was characterized by a slow rate of increase in turbidity without a corresponding increase in numbers of CFU or synthesis of DNA. However, a high rate of production of glycine dehydrogenase was initiated and sustained while the bacilli were in this state, and a steady ATP concentration was maintained. When the dissolved O2 content of the culture dropped below about 0.06% saturation, the bacilli shifted down abruptly to an anaerobic stage, designated NRP stage 2, in which no further increase in turbidity was seen and the concentration of glycine dehydrogenase declined markedly. The ability of bacilli in NRP stage 2 to survive anaerobically was dependent in part on having spent sufficient transit time in NRP stage 1. The effects of four antimicrobial agents on the bacilli depended on which of the different physiologic stages the bacilli occupied at a given time and reflected the recognized modes of action of these agents. It is suggested that the ability to shift down into one or both of the two nonreplicating stages, corresponding to microaerophilic and anaerobic persistence, is responsible for the ability of tubercle bacilli to lie dormant in the host for long periods of time, with the capacity to revive and activate disease at a later time. The model described here holds promise as a tool to help clarify events at the molecular level that permit the bacilli to persist under adverse conditions and to resume growth when conditions become favorable. The culture model presented here is also useful for screening drugs for the ability to kill tubercle bacilli in their different stages of nonreplicating persistence.

Full Text

The Full Text of this article is available as a PDF (278.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cambau E., Sougakoff W., Jarlier V. Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria. FEMS Microbiol Lett. 1994 Feb 1;116(1):49–54. doi: 10.1111/j.1574-6968.1994.tb06674.x. [DOI] [PubMed] [Google Scholar]
  2. Dhople A. M., Hanks J. H. Quantitative extraction of adenosine triphosphate from cultivable and host-grown microbes: calculation of adenosine triphosphate pools. Appl Microbiol. 1973 Sep;26(3):399–403. doi: 10.1128/am.26.3.399-403.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dickinson J. M., Mitchison D. A. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):367–371. doi: 10.1164/arrd.1981.123.4.367. [DOI] [PubMed] [Google Scholar]
  4. Edwards D. I. Mechanism of antimicrobial action of metronidazole. J Antimicrob Chemother. 1979 Sep;5(5):499–502. doi: 10.1093/jac/5.5.499. [DOI] [PubMed] [Google Scholar]
  5. GOLDMAN D. S., WAGNER M. J. Enzyme systems in the mycobacteria. XIII. Glycine dehydrogenase and the glyoxylic acid cycle. Biochim Biophys Acta. 1962 Dec 4;65:297–306. doi: 10.1016/0006-3002(62)91048-x. [DOI] [PubMed] [Google Scholar]
  6. Harshey R. M., Ramakrishnan T. Rate of ribonucleic acid chain growth in Mycobacterium tuberculosis H37Rv. J Bacteriol. 1977 Feb;129(2):616–622. doi: 10.1128/jb.129.2.616-622.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaprelyants A. S., Gottschal J. C., Kell D. B. Dormancy in non-sporulating bacteria. FEMS Microbiol Rev. 1993 Apr;10(3-4):271–285. doi: 10.1111/j.1574-6968.1993.tb05871.x. [DOI] [PubMed] [Google Scholar]
  8. Shoeb H. A., Bowman B. U., Jr, Ottolenghi A. C., Merola A. J. Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother. 1985 Mar;27(3):404–407. doi: 10.1128/aac.27.3.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Takayama K., Wang L., David H. L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1972 Jul;2(1):29–35. doi: 10.1128/aac.2.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wayne L. G. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):908–914. doi: 10.1007/BF02111491. [DOI] [PubMed] [Google Scholar]
  11. Wayne L. G. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am Rev Respir Dis. 1976 Oct;114(4):807–811. doi: 10.1164/arrd.1976.114.4.807. [DOI] [PubMed] [Google Scholar]
  12. Wayne L. G., Lin K. Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immun. 1982 Sep;37(3):1042–1049. doi: 10.1128/iai.37.3.1042-1049.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wayne L. G., Sramek H. A. Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis. Infect Immun. 1979 May;24(2):363–370. doi: 10.1128/iai.24.2.363-370.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wayne L. G., Sramek H. A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1994 Sep;38(9):2054–2058. doi: 10.1128/aac.38.9.2054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wayne L. G. Synchronized replication of Mycobacterium tuberculosis. Infect Immun. 1977 Sep;17(3):528–530. doi: 10.1128/iai.17.3.528-530.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES